The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

The US FDA approved an RSV vaccine called Arexvy. How effective is it, when will it be available, and who can take it? CNN Medical Analyst Dr. Leana Wen explains.

Winter is here, and with it come higher rates of respiratory illnesses. If you've been struck down recently with a sore ...

Two recent studies published this week assess the low uptake of respiratory syncytial virus (RSV) vaccine among US veterans and examine the risk factors for intensive care unit (ICU) admission and ...

Anyone 3 or older can get a flu shot, and adults 60 and older are eligible for the RSV vaccine. Rite Aid also plans to announce availability of those vaccines soon, spokesperson Catherine Carter says.

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

Currently, there is no vaccine that exists for RSV, and infants younger than 6 months old are too young to receive most vaccines recommended by the Centers for Disease Control and Prevention. 4.

RSV: A vaccine targeting respiratory syncytial virus (RSV) has been approved for adults age 60 and older. Monoclonal antibody products (which are not vaccines) are also available to protect ...

RSV vaccines for babies, older adults and pregnant people are in the works from several companies. Here's the latest data and information. Hotspots ranked Start the day smarter ☀️ Funniest cap ...

Sanofi is buying Vicebio for more than $1 billion, picking up an experimental vaccine targeting RSV and another respiratory bug.